ADVERTISEMENT
search.svg

COVID-19 Vaccines

COVID-19 Vaccines

Featured Updates

Pfizer-BioNTech COVID-19 Vaccine Booster Dose

This course will review clinical data supporting the recommendation for a booster dose in these populations and shed light on why other groups are not currently candidates.

Moderna COVID-19 Vaccine Booster Dose

This course will review clinical evidence and safety data as well as guidance on mix-and-match booster doses between the Moderna, Pfizer-BioNTech, and Janssen vaccines.

Janssen COVID-19 Vaccine Booster Dose

This course will review the clinical evidence and safety data as well as additional information on Thrombosis with Thrombocytopenia Syndrome (TTS) and Guillain-Barre Syndrome (GBS).

Overview

COVID-19 Vaccine Dosing Labels (January 24, 2022)
Download and print COVID-19 vaccine dosing labels to incorporate into your workflows and maintain patient safety.(APhA Know the Facts – PDF)

COVID-19 Vaccine Summary Chart (January 14, 2022)
Reference key information about the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines and the CDC's clinical considerations.(APhA Know the Facts – PDF)

COVID-19 Vaccine Algorithm (January 13, 2022)
A practice tool to determine patient eligibility, timing, and use of COVID-19 vaccines for primary, additional, and/or booster doses. (APhA Know the Facts – PDF)

COVID-19 Vaccine Booster Doses Recommended for Certain Individuals (December 2, 2021)
FAQ about COVID-19 booster doses, including information about mixing-and-matching booster doses, who is eligible, and how to document the dose. (APhA Know the Facts – HTML)

COVID-19 Multidose Vial Technique (October 26, 2021)
Did you know that many COVID-19 vaccine formulations do not contain preservatives? Some of the new recommendations for COVID-19 vaccine booster doses may significantly increase the number of times a vial of COVID-19 vaccine is accessed. This in-depth video will walk you through all aspects of appropriate sterile technique when accessing COVID-19 vaccine vials, from hand hygiene to selecting a work space, and drawing up a dose. APhA gratefully acknowledges Moderna’s support of the production of this video. (Education During COVID-19 – Video)

Providing At-Home Vaccinations (June 24, 2021)
Hear how pharmacists are expanding access to the COVID-19 vaccine by going to the patient’s home; learn about new Medicare payment opportunities for at-home vaccinations. (APhA Open Forum Webinar - Video - Slides)

COVID-19 Vaccine Pharmacy Provider Tool (May 11, 2021)
Check this list of references and recommendations to verify that your pharmacy and staff can successfully administer COVID-19 vaccines. (APhA Know the Facts—PDF)

Reproductive Health: The Impact of COVID-19 Disease and Vaccination (April 22, 2021)
Learn how to talk with patients about reproductive health concerns, including pregnancy, breastfeeding, and fertility. (APhA Open Forum Webinar - Video - Slides)

New England Journal of Medicine's COVID-19 Vaccine Resource Center is a collection of information, research, and Frequently Asked Questions.

CDC's COVID-19 Vaccination page is a collection of resources to help health care providers prepare to vaccinate patients.

CDC's Selected Adverse Events Reported after COVID-19 Vaccination has information for patients about adverse events reported after vaccination such as anaphylaxis, thrombosis with thrombocytopenia and myocarditis.

 
Frontline Perspectives

Public Health Partnerships in Practice (March 4, 2021)
Hear from pharmacists who have partnered with community public health efforts to increase COVID-19 vaccination and reach underserved and high-risk patient populations. (APhA Open Forum Webinar - Video - Slides)

Student Pharmacist Involvement in COVID-19 Vaccination (January 21, 2021)
Hear about successes and barriers to student involvement in COVID-19 vaccination efforts. Whether you are a faculty member at a school of pharmacy, a practicing pharmacist who works with students, or a student pharmacist, gain practical insights from this webinar in collaboration with the American Association of Colleges of Pharmacy! (APhA Weekly Open Forum Webinar - Video - Slides)

COVID-19 Vaccine Frontline Perspectives (January 7, 2021)
Hear frontline pharmacists discuss COVID-19 vaccination logistical considerations, implementation strategies, key administration information, and other factors that facilitate successful vaccine administration. (APhA Weekly Open Forum Webinar - Video - Slides)

CDC's VaccineFinder Public Display Checklist for Pharmacies using the COVID Locating Health Provider Portal provides instructions for VaccineFinder.org, a national resource of COVID-19 vaccine providers to help consumers find provider locations that carry COVID-19 vaccines near them and learn how to make an appointment.

 
Storage and Administration

Maximizing COVID-19 Vaccine Doses (June 23, 2021)
Recommendations for vaccine withdrawal and administration techniques to decrease variability between doses. (APhA Know the Facts - PDF)

Understanding Dead Space (February 1)
Learn the steps you can take to maximize the number of available COVID-19 vaccine doses. Join us as we explain the concept of dead space, why it matters, and what you can do to minimize it, and finally review techniques to ensure that you are getting as many doses of COVID-19 vaccine out of each vial. (APhA 15 on COVID-19 - CPE Video)

USP's COVID-19 Vaccine Handling Toolkit provides strategies that help increase vaccinations while supporting safe handling and quality.

CDC's Vaccine Administration Resource Library provides videos and references for vaccine providers including information on needle gauge and length, I.M. injection adults 19 years of age and older, and I.M. injection children 7-18 years of age.

 
Documentation and Billing

Reimbursement for Administration of COVID-19 Vaccine(s)—What We Know (September 22, 2021)
This resource provides an overview of what we know about COVID-19 vaccine reimbursement at this time and covers steps pharmacists can take now to be positioned as a COVID-19 vaccine provider.(PDF)

CMS's Medicare Payment for COVID-19 Vaccination Administration in the Home has important updates on increased reimbursement for at-home COVID-19 vaccinations.

HRSA COVID-19 Uninsured Program and Coverage Assistance Fund: Updates for Pharmacy (June 4, 2021)
A guide to reimbursement for COVID-19 services delivered to uninsured individuals or those without coverage for these services. (APhA Know the Facts—PDF)

CDC's VaxText COVID-19 Vaccination Second-Dose Reminder is a free messaging program that providers can recommend to patients.

Monitoring COVID-19 Vaccine Safety: VAERS and V-SAFE (December 10, 2020)
Hear from Tanya Myers, PhD, MSc, the v-safe team lead for the CDC, as she provides a brief overview of two vaccine safety monitoring platforms pharmacists should be aware of. (APhA Weekly Open Forum Webinar Excerpt - Video - Slides)

 

mRNA COVID-19 Vaccines

Additional Dose Recommended for Certain Immunocompromised Individuals (August 18, 2021)
FAQ about additional doses of mRNA COVID-19 vaccines and summary of key clinical considerations.(APhA Know the Facts—HTML - PDF)

CDC's Clinical Considerations for Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults provides background on this reported adverse events and recommendations for clinicians.

mRNA Vaccines (July 24, 2020)
This episode looks at the new mRNA vaccine technology, and look at the early data to see if they are a viable option for preventing COVID-19. (APhA 15 on COVID-19 - CPE)

Pfizer-BioNTech

Pfizer-BioNTech COVID-19 Vaccine Booster Dose (October 18, 2021)
A significant change to the Pfizer-BioNTech COVID-19 vaccine’s Emergency Use Authorization involves the recommendation for booster doses in specific patient populations. This course will review clinical data supporting the recommendation for a booster dose in these populations and shed light on why other groups are not currently candidates. (Education During COVID-19 – CPE)

Pfizer-BioNtech COVID-19 Vaccine Booster Dose (October 18, 2021)
A significant change to the Pfizer-BioNTech COVID-19 vaccine’s emergency use authorization involves the recommendation for booster doses in specific patient populations.
This course will review clinical data supporting the recommendation for a booster dose in these populations and shed light on why other groups are not currently candidates. It will also cover the clinical evidence and safety data for booster doses. (APhA Education During COVID-19 – CPE)

Pfizer-BioNTech COVID-19 Booster Doses Recommended for Certain Individuals (October 5, 2021)
FAQ about booster doses of the Pfizer-BioNTech COVID-19 vaccine, including who is eligible and how to document the dose. (APhA Know the Facts—HTML)

Pfizer-BioNTech COVID-19 Vaccine Overview (December 10, 2020)
An overview of the Pfizer-BioNTech COVID-19 vaccine: mechanism of action; efficacy and safety data; storage; handling; and dose preparation and administration. (APhA COVID-19 Education—CPE)

CDC's Pfizer-BioNTech COVID-19 Vaccine provides administration and storage information, as well as clinical considerations.

FDA's Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers and for Recipients and Caregivers.

Moderna

Moderna COVID-19 Vaccine Booster Dose (October 28, 2021)
A significant change to the Moderna COVID-19 vaccine’s Emergency Use Authorization involves the recommendation for booster doses in specific patient populations. Join us in reviewing the clinical evidence and safety data for Moderna’s booster dose and guidance on mix-and-match booster doses between the Moderna, Pfizer-BioNTech, and Janssen vaccines. (Education During COVID-19 – CPE)

Moderna COVID-19 Vaccine (mRNA-1273) (February 10)
This overview of the Moderna vaccine (mRNA-1273) covers the mechanism of action, efficacy, and safety data; storage and handling information; and vaccine hesitancy data. This one-stop program will cover everything you need to know about the vaccine. (APhA 15 on COVID-19 - CPE Video)

CDC's Moderna COVID-19 Vaccine provides administration and storage information, as well as clinical considerations.

FDA's Moderna COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers and for Recipients and Caregivers

 

Viral Vector COVID-19 Vaccines

Janssen COVID-19 Vaccine Booster Dose (November 3, 2021)
This course will review the clinical evidence and safety data as well as additional information on Thrombosis with Thrombocytopenia Syndrome (TTS) and Guillain-Barre Syndrome (GBS). (APhA Education During COVID-19 – CPE)

Janssen COVID-19 Vaccine (J&J) Overview—What Pharmacists Need to Know (March 18, 2021)
Join us for an overview of the Janssen (J&J) COVID-19 vaccine as we review the mechanism of action, efficacy and safety data, storage and handling information, and vaccine hesitancy data. This one-stop program will cover everything you need to know about the vaccine. (APhA 15 on COVID-19 - CPE Video)

Adenovirus Vector Technology (March 3, 2021)
We examine how adenovirus-based vaccines work, answer some of the common questions that patients may be asking, and look at the history of adenovirus-based vaccines. (APhA 15 on COVID-19 - CPE Video)

CDC's Janssen (J&J) COVID-19 Vaccine provides administration and storage information as well as clinical considerations.

FDA's Janssen (J&J) COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers and for recipients and caregivers.

CDC issued a health alert (April 13) regarding cases of a rare type of blood clot in individuals after receiving the Janssen (J&J) COVID-19 vaccine. The alert includes recommendations for clinicians.

Adolescent COVID-19 Vaccination

COVID-19 Vaccination in Adolescents and Children (January 12, 2022)
Reference this FAQ about the use and safety of the Pfizer-BioNTech COVID-19 vaccine in children and adolescents, including key differences in the administration and storage of the pediatric-indicated vaccine and the adolescent/adult-indicated vaccine. (APhA Know the Facts – PDF)

CDC's How to Talk with Parents About COVID-19 Vaccination collects resources to inform conversations with parents and guardians.

CDC's Covid-19 Vaccines for Children and Teens is an informative webpage you can share with patients.

CDC's Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States – Vaccination of Children and Adolescents outlines guidance on obtaining appropriate assent and reminds providers of the risk of syncope after injection.

 

Key Links

Testing in Pharmacies

COVID-19 Vaccines

Immunizing during COVID-19

Managing your Pharmacy

Telehealth

Advocacy Opportunities

Well-being

Compounding

Medications Being Studied

All COVID-19 Resources